105 related articles for article (PubMed ID: 12920756)
21. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
Krishnappa P; Mohamad IB; Lin YJ; Barua A
Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
23. [The p16INK4A mRNA transcripts estimation in cervical smear with different degrees of cervical dysplasia].
Janušicová V; Kapustová I; Zúbor P; Slezák P; Kajo K; Lasabová Z; Plank L; Danko J
Ceska Gynekol; 2012 Jun; 77(3):245-50. PubMed ID: 22779728
[TBL] [Abstract][Full Text] [Related]
24. Immunofluorescence expression of Ki-67, p53 and cyclin inhibitors (p16ink4a, p21 and p27) in low-grade cervical lesions versus high-grade cervical lesions. Research study on cell cultures.
Stănculescu R; Ceauşu M; Ceauşu Z; Bausic V
Rom J Morphol Embryol; 2013; 54(3 Suppl):725-34. PubMed ID: 24322019
[TBL] [Abstract][Full Text] [Related]
25. P16INK4A--A possible marker in HPV persistence screening.
Bleotu C; Botezatu A; Goia CD; Socolov D; Corniţescu F; Teleman S; Huică I; Iancu I; Anton G
Roum Arch Microbiol Immunol; 2009; 68(3):183-9. PubMed ID: 20361540
[TBL] [Abstract][Full Text] [Related]
26. Liquid-based cytology for primary cervical cancer screening: a multi-centre study.
Monsonego J; Autillo-Touati A; Bergeron C; Dachez R; Liaras J; Saurel J; Zerat L; Chatelain P; Mottot C
Br J Cancer; 2001 Feb; 84(3):360-6. PubMed ID: 11161401
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
[TBL] [Abstract][Full Text] [Related]
30. Liquid-based cervical-cell collection with brushes and wooden spatulas: a comparison of 100 conventional smears from high-risk women to liquid-fixed cytocentrifuge slides, demonstrating a cost-effective, alternative monolayer slide preparation method.
Johnson T; Maksem JA; Belsheim BL; Roose EB; Klock LA; Eatwell L
Diagn Cytopathol; 2000 Feb; 22(2):86-91. PubMed ID: 10649517
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
[TBL] [Abstract][Full Text] [Related]
32. Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions.
Samarawardana P; Singh M; Shroyer KR
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):514-8. PubMed ID: 21602668
[TBL] [Abstract][Full Text] [Related]
33. P16INK4A and MIB-1: an immunohistochemical expression in preneoplasia and neoplasia of the cervix.
Srivastava S
Indian J Pathol Microbiol; 2010; 53(3):518-24. PubMed ID: 20699515
[TBL] [Abstract][Full Text] [Related]
34. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the pulse wash sampling technique for screening of uterine cervical carcinoma.
Näslund I; Auer G; Pettersson F; Sjövall K
Acta Radiol Oncol; 1986; 25(2):131-6. PubMed ID: 3012957
[TBL] [Abstract][Full Text] [Related]
36. [Expression and significance of P16INK4A and PTEN in high-risk human papillomavirus-related cervical cancer].
Zhao XL; Cheng SX; Kong XD
Ai Zheng; 2007 May; 26(5):480-3. PubMed ID: 17672936
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical detection of HPV16 E7 in cervical smear.
Jeon JH; Shin DM; Cho SY; Song KY; Park NH; Kang HS; Kim YD; Kim IG
Exp Mol Med; 2007 Oct; 39(5):621-8. PubMed ID: 18059138
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.
Sahebali S; Depuydt CE; Boulet GA; Arbyn M; Moeneclaey LM; Vereecken AJ; Van Marck EA; Bogers JJ
Int J Cancer; 2006 Mar; 118(5):1254-60. PubMed ID: 16161049
[TBL] [Abstract][Full Text] [Related]
39. Implementation and evaluation of a new automated interactive image analysis system.
Bolger N; Heffron C; Regan I; Sweeney M; Kinsella S; McKeown M; Creighton G; Russell J; O'Leary J
Acta Cytol; 2006; 50(5):483-91. PubMed ID: 17017432
[TBL] [Abstract][Full Text] [Related]
40. Temporal characteristics of laboratory screening errors in cervical cytology.
Mitchell H; Hocking J; Saville M
Acta Cytol; 2006; 50(5):492-8. PubMed ID: 17017433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
